PNC FINANCIAL SERVICES GROUP, INC. - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$80,700
-25.9%
100,8750.0%0.00%
Q2 2023$108,945
+37.6%
100,8750.0%0.00%
Q1 2023$79,187
+26.2%
100,8750.0%0.00%
Q4 2022$62,744
-47.7%
100,8750.0%0.00%
Q3 2022$120,000
-29.0%
100,8750.0%0.00%
Q2 2022$169,000
+201.8%
100,875
+301.5%
0.00%
Q1 2022$56,000
-34.9%
25,1250.0%0.00%
Q4 2021$86,00025,1250.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,059,383$1,780,0001.21%
Quantum Private Wealth, LLC 10,000$16,0000.01%
Warberg Asset Management LLC 19,500$33,0000.01%
OSAIC HOLDINGS, INC. 160$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$169,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
NORTHERN TRUST CORP 15,221$26,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,223$111,0000.00%
MORGAN STANLEY 18,016$30,0000.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders